A malignant melanoma tumor suppressor on human chromosome 11
- PMID: 8813145
A malignant melanoma tumor suppressor on human chromosome 11
Abstract
Considerable molecular genetic and cytogenetic evidence indicates that chromosome 11 is a target for chromosome breakage, rearrangement, and loss during the development of human malignant melanomas. Abnormalities of the long arm of chromosome 11 are also evident in a wide variety of other human solid tumors, including carcinomas of the breast, ovary, cervix, and lung. In melanomas, these abnormalities tend to cluster in the lower half of the long arm of chromosome 11, indicating the possible presence of a melanoma tumor suppressor gene in this region. We tested this possibility by using microcell-mediated chromosome transfer to introduce normal copies of human chromosome 11 into two human malignant melanoma cell lines. In one cell line, MelJuSo, the presence of an additional copy of chromosome 11 severely reduced the ability of the cells to grow in culture. In a second cell line, UACC 903, there was a moderate reduction in cell growth in vitro, and the ability of the hybrid cells to form tumors in animals was suppressed. Suppression of tumorigenicity was even more strongly pronounced in a microcell hybrid that received an isochromosome 11q derived from the donor copy of chromosome 11. The formation of tumors was accompanied by a reduction in the copy number of chromosome 11. This provides functional evidence that a melanoma tumor suppressor resides on the long arm of chromosome 11. Thus, a third distinct locus, in addition to those previously defined on chromosomes 6 and 9, appears to play a role in the development of human malignant melanoma.
Similar articles
-
Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.Mol Carcinog. 2002 Nov;35(3):148-56. doi: 10.1002/mc.10080. Mol Carcinog. 2002. PMID: 12410566
-
Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.Mol Carcinog. 1996 Apr;15(4):284-99. doi: 10.1002/(SICI)1098-2744(199604)15:4<284::AID-MC6>3.0.CO;2-G. Mol Carcinog. 1996. PMID: 8634087
-
Mechanisms of human melanoma cell growth and tumor suppression by chromosome 6.Cancer Res. 1996 Apr 1;56(7):1635-41. Cancer Res. 1996. PMID: 8603413
-
Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer.Oncogene. 2002 Oct 7;21(45):6936-48. doi: 10.1038/sj.onc.1205825. Oncogene. 2002. PMID: 12362275 Review.
-
Chromosome alterations in human malignant melanoma.Carcinog Compr Surv. 1989;11:165-86. Carcinog Compr Surv. 1989. PMID: 2646015 Review.
Cited by
-
Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.BMC Cancer. 2012 Feb 22;12:73. doi: 10.1186/1471-2407-12-73. BMC Cancer. 2012. PMID: 22356677 Free PMC article.
-
Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma.PLoS One. 2017 Oct 3;12(10):e0185730. doi: 10.1371/journal.pone.0185730. eCollection 2017. PLoS One. 2017. PMID: 28973033 Free PMC article.
-
European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Breast Cancer Somatic Genetics Consortium.Br J Cancer. 1999 May;80(5-6):879-82. doi: 10.1038/sj.bjc.6690435. Br J Cancer. 1999. PMID: 10360669 Free PMC article.
-
Detailed deletion mapping at chromosome 11q23 in colorectal carcinoma.Br J Cancer. 2000 Sep;83(6):750-5. doi: 10.1054/bjoc.2000.1366. Br J Cancer. 2000. PMID: 10952779 Free PMC article.
-
In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9418-23. doi: 10.1073/pnas.95.16.9418. Proc Natl Acad Sci U S A. 1998. PMID: 9689095 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical